Inventor · disambiguated record
Ute Egerland
Also filed as: EGERLAND UTE
22 granted patents·10 pending applications·308 citations·filing 1999–2018
96Inventor score
Top patents by PatentIndex Score
32 records- 0193US6613794B2Hydroxyindoles, their use as inhibitors of phosphodiesterase 4 and processes for their preparationDRESDEN ARZNEIMITTEL·Filed 2003·Granted Sep 2, 2003·36 cites·26 claims
- 0293US6602890B2Hydroxyindoles, their use as inhibitors of phosphodiesterase 4 and processes for their preparationDRESDEN ARZNEIMITTEL·Filed 2002·Granted Aug 5, 2003·36 cites·31 claims
- 0392US9981950B2Triazoles as NR2B receptor inhibitorsJANSSEN PHARMACEUTICALS INC·Filed 2015·Granted May 29, 2018·17 cites·28 claims
- 0492US6251923B1Hydroxyindoles, their use as inhibitors of phosphodiesterase 4 and process for their preparationDRESDEN ARZNEIMITTEL·Filed 1999·Granted Jun 26, 2001·74 cites·14 claims
- 0591US10323021B2Triazoles as NR2B receptor inhibitorsJANSSEN PHARMACEUTICALS INC·Filed 2018·Granted Jun 18, 2019·13 cites·32 claims
- 0690US6545158B2Hydroxyindoles, their use as inhibitors of phosphodiesterase 4 and processes for their preparationDRESDEN ARZNEIMITTEL·Filed 2002·Granted Apr 8, 2003·23 cites·4 claims
- 0789US10155727B2PyrazolesJANSSEN PHARMACEUTICALS INC·Filed 2015·Granted Dec 18, 2018·15 cites·32 claims
- 0889US6545025B2Hydroxyindoles, their use as inhibitors of phosphodiesterase 4 and processes for their preparationDRESDEN ARZNEIMITTEL·Filed 2002·Granted Apr 8, 2003·22 cites·31 claims
- 0988USRE38624EHydroxyindoles, their use as inhibitors of phosphodiesterase 4 and process for their preparationELBION AG·Filed 2002·Granted Oct 12, 2004·20 cites·14 claims
- 1081US7169787B27-azaindoles, use thereof as phosphodiesterase 4 inhibitors and method for producing the sameELBION AG·Filed 2001·Granted Jan 30, 2007·14 cites·11 claims
- 1180US7419987B27-azaindoles, their use as inhibitors of phosphodiesterase 4, and a method for synthesizing themELBION AG·Filed 2006·Granted Sep 2, 2008·4 cites·2 claims
- 1277US9085584B2Substituted pyrido[3,2-E][1,2,4]-triazolo[4,3-A]pyrazines for the treatment of central nervous system disordersGIOVANNINI RICCARDO·Filed 2013·Granted Jul 21, 2015·5 cites·34 claims
- 1377US7550465B2Pyrido[3,2-e]pyrazines, their use as inhibitors of phosphodiesterase 10, and processes for preparing themELBION GMBH·Filed 2007·Granted Jun 23, 2009·6 cites·11 claims
- 1476US7875618B2Substituted imidazo[1,5-a]quinoxalines useful as inhibitors of phosphodiesterase 10 for the treatment of neurological and other disordersWYETH CORP·Filed 2008·Granted Jan 25, 2011·3 cites·50 claims
- 1575US7166637B2Hydroxyindoles, their use as inhibitors of phosphodiesterase 4, and processes for preparing themELBION AG·Filed 2003·Granted Jan 23, 2007·12 cites·16 claims
- 1674US6465465B1Process for the treatment of erectile dysfunction and product thereforDRESDEN ARZNEIMITTEL·Filed 2001·Granted Oct 15, 2002·4 cites·8 claims
- 1762US7067536B24-,6- or 7-hydroxyindoles with N-oxide groups and the use thereof as therapeutic agentsELBION AG·Filed 2004·Granted Jun 27, 2006·2 cites·7 claims
- 1861US7211583B27-azaindoles and the use thereof as therapeutic agentsELBION AG·Filed 2004·Granted May 1, 2007·2 cites·14 claims
- 1959US2004220183A1Hydroxyindoles, their use as inhibitors of phosphodiesterase 4 and processes for their preparationFiled 2004·Application pending·0 cites
- 2058US2009239874A1Pyrido[3,2-e]pyrazines, their use as inhibitors of phospohodiesterase 10, and processes for preparing themHOFGEN NORBERT·Filed 2009·Application pending·0 cites
- 2156US7683074B27-azaindoles, their use as inhibitors of phosphodiesterase 4, and a method for synthesizing themBIOTIE THERAPIES GMBH·Filed 2008·Granted Mar 23, 2010·0 cites·14 claims
- 2254US7161009B2Hydroxyindoles, their use as inhibitors of phosphodiesterase 4 and processes for their preparationELBION AG·Filed 2002·Granted Jan 9, 2007·0 cites·30 claims
- 2351US2010120763A1Imidazo[5,1-c][1,2,4]benzotriazine derivatives as inhibitors of phosphodiesterasesWYETH CORP·Filed 2009·Application pending·0 cites
- 2451US2010120762A1Triazine derivatives as inhibitors of phosphodiesterasesWYETH CORP·Filed 2009·Application pending·0 cites
- 2549US2007093531A1Novel hydroxyindoles, their use as inhibitors of phosphodiesterase 4, and processes for preparing themELBION AG·Filed 2006·Application pending·0 cites
- 2649US2009143391A1Aryl and heteroaryl fused imidazo [1,5-a] pyrazines as inhibitors of phosphodiesterase 10HOFGEN NORBERT·Filed 2008·Application pending·0 cites
- 2747US7947705B27-azaindoles and the use thereof as therapeutic agentsBIOTIE THERAPIES GMBH·Filed 2007·Granted May 24, 2011·0 cites·6 claims
- 2846US2006128758A14-,6- or 7-hydroxyindoles with N-oxide groups and the use thereof as therapeutic agentsHOFGEN NOBERT·Filed 2006·Application pending·0 cites
- 2944US2009143361A1Pyrido[3,2-E]Pyrazines, Process For Preparing The Same, And Their Use As Inhibitors Of Phosphodiesterase 10ELBION GMBH·Filed 2008·Application pending·0 cites
- 3043US2009143392A1Methods of Treating Obesity and Metabolic DisordersELBION GMBH·Filed 2008·Application pending·0 cites
- 3141USRE49517EPyrazolesJANSSEN PHARMACEUTICALS INC·Filed 2015·Granted May 2, 2023·0 cites·32 claims
- 3241US2004266760A15-hydroxyindoles with N-oxide groups and the use thereof as therapeutic agentsFiled 2004·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ute Egerland files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →